Moderna | MRNA - Cash And Equivalent



Moderna reported $1.28B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Acadia Pharmaceuticals USD 762M 80.42M Jun/2025
Adcock Ingram Holdings ZAR 79.14M 10.28M Dec/2024
Agios Pharmaceuticals USD 80.87M 1.91M Jun/2025
Alnylam Pharmaceuticals USD 1.11B 94.03M Jun/2025
Amgen USD 8.03B 782M Jun/2025
Arrowhead Research USD 129.79M 55.92M Jun/2025
Biogen USD 2.76B 160.5M Jun/2025
BioMarin Pharmaceutical USD 1.21B 601.78M Jun/2025
Celltrion KRW 829.07B 829.07B Mar/2025
Cspc Pharmaceutical 6.78B 1.6B Dec/2024
Dianthus Therapeutics USD 13.24M 9.56M Jun/2025
Divis Laboratories Ltd 4.15B 31.87B Mar/2025
Gilead Sciences USD 5.14B 2.78B Jun/2025
GlaxoSmithKline GBP 3.6B 865M Jun/2025
Incyte USD 2.42B 13.08M Jun/2025
Ionis Pharmaceuticals USD 297.3M 33.11M Jun/2025
Kangmei Pharma CNY 894.14M 120.63M Mar/2025
Knight Therapeutics CAD 5.81M 3.59M Sep/2024
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Moderna USD 1.28B 344M Jun/2025
Organigram Holdings 35.88M 8.42M Jun/2025
Pharma Mar EUR 21.59M 38.7M Jun/2025
Qiagen NV USD 733.82M 95.06M Jun/2025
Regeneron Pharmaceuticals USD 2B 1.09B Jun/2025
Sarepta Therapeutics USD 510.6M 269.73M Jun/2025
Sartorius EUR 819M 20.5M Jun/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Tilray USD 189.7M 15.49M Nov/2024
Ultragenyx Pharmaceutical USD 166.11M 396.9M Jun/2025
United Therapeutics USD 1.59B 306.8M Jun/2025
Vertex Pharmaceuticals USD 6.38B 1.71B Jun/2025
Zz Pientze Pharmaceu 1.39B 93.82M Mar/2025